Analytical Validation of Minimally Invasive Capillary Blood Microsampling using Tasso+ for Multiplexed Neurological Biomarkers
Swann, O.; Hicks, S.; Lynch, C.; Wallman-Jones, A.; Shoai, M.; Mulvaney, R.; Fernandes Gomes, B.; Kodosaki, E.; Tecilla, M.; Ghajari, M.; Jones, B.; Kemp, S.; TBI-REPORTER Biomarker group, ; Sylvester, R.; Cross, M.; Stokes, K.; Wilson, M. G.; Menon, D. K.; Heslegrave, A.; Zetterberg, H.; Sharp, D. J.; Parker, T. D.
Show abstract
Blood-based biomarkers are increasingly used to investigate brain health, but collecting venous blood is difficult in remote and field settings. Capillary microsampling offers a practical alternative, although the ability to delay processing and its agreement with gold-standard venous blood require validation. We evaluated Tasso+, a minimally invasive upper-arm capillary blood collection system, for measuring neurological and host-response biomarkers in plasma and serum during an exercise-based protocol. Sampling occurred before, immediately after, and approximately 24-to-36 hours after exercise; Tasso+ samples were processed with or without a 72-hour room-temperature delay. Tasso+ samples were compared with matched venous blood, and Capitainer SEP10 dried plasma spots were also evaluated, using Quanterix Simoa and Alamar Biosciences NULISAseq CNS panel. Tasso+ enabled reliable measurement of several key biomarkers, including GFAP and NfL, even after delayed processing. These findings support capillary microsampling for neurological biomarker studies where venepuncture is challenging, including field-based research and participant-led remote sampling.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.